Combination of miglitol, an anti‐diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial KATP channels in rabbits

[1]  C. Spencer,et al.  Miglitol , 2000, Drugs.

[2]  M. Arai,et al.  A novel anti‐diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits , 1999, British journal of pharmacology.

[3]  HisatoTakatsu,et al.  N-Methyl-1-Deoxynojirimycin (MOR-14), an α-Glucosidase Inhibitor, Markedly Reduced Infarct Size in Rabbit Hearts , 1998 .

[4]  M. Arai,et al.  N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts. , 1998, Circulation.

[5]  D. Yellon,et al.  Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. , 1998, Journal of cardiovascular pharmacology.

[6]  M. Arai,et al.  Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits. , 1997, International journal of cardiology.

[7]  E. Brendel,et al.  Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. , 1997, Arzneimittel-Forschung.

[8]  M. Karmazyn,et al.  Transient ischemia in the presence of an adenosine deaminase plus a nucleoside transport inhibitor confers protection against contractile depression produced by hydrogen peroxide. Possible role of glycogen. , 1996, Journal of molecular and cellular cardiology.

[9]  R. Sievers,et al.  Loss of Myocardial Protection After Preconditioning Correlates With the Time Course of Glycogen Recovery Within the Preconditioned Segment , 1993, Circulation.

[10]  R. Prager,et al.  Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic Patients , 1989, Diabetes Care.

[11]  M. Bollen,et al.  The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the alpha-1,6-glucosidase activity of the debranching enzyme. , 1989, European journal of biochemistry.

[12]  G. Radda,et al.  Determination of buffering capacity of rat myocardium during ischemia. , 1988, Biochimica et biophysica acta.

[13]  Y. Yoshikuni.  Inhibition of Intestinal α-Glucosidase Activity and Postprandial Hyperglycemia by Moranoline and Its N-Alkyl Derivatives , 1988 .

[14]  J. R. Neely,et al.  Role of Glycolytic Products in Damage to Ischemic Myocardium: Dissociation of Adenosine Triphosphate Levels and Recovery of Function of Reperfused Ischemic Hearts , 1984, Circulation research.

[15]  J. Haselgrove,et al.  Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey. , 1981, The American journal of physiology.

[16]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.